Increased Levels of Soluble LR11 in Cerebrospinal Fluid of Patients with Alzheimer Disease

These results suggest that the quantification of CSF sLR11 may serve as a biomarker of AD, although the diagnostic value for individual patients is limited. An elevated CSF sLR11 level in AD patients may be relevant to AD pathogenesis.